NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MyabA.00213.a: Putative enoyl-CoA hydratase/isomerase

Target Characteristics

from organism: Mycobacterium abscessus ATCC 19977 / DSM 44196
most recent status: native diffraction-data
center reference id: MyabA.00213.a
is community request: False
associated disease: Skin abscess
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyabA.00213.a.A1.GE30264 Full length( MyabA.00213.a ) 1 306 GE30264
MyabA.00213.a.AE1.GE43331 Full length( MyabA.00213.a ) 1 306 GE43331
MyabA.00213.a.B1.GE43060 Full length( MyabA.00213.a ) 1 306 GE43060
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyabA.00213.a.AE1.PS38634 Full length( MyabA.00213.a ) 1 306

External Resources

Resource Reference ID
OrthoMCL: OG5_129459
PATRIC ID: fig|36809.5.peg.3412
RefSeq: YP_001704080.1
UniProt: B1MDV7

Enzyme & Pathway Information

Pathway Pathway ID EC Number
fatty acid beta-oxidation I FAO-PWY 4.2.1.17
L-isoleucine degradation I ILEUDEG-PWY 4.2.1.17
oleate beta-oxidation PWY0-1337 4.2.1.17
phenylacetate degradation I (aerobic) PWY0-321 4.2.1.17
benzoyl-CoA degradation I (aerobic) PWY-1361 4.2.1.17
fermentation to 2-methylbutanoate PWY-5109 4.2.1.17
fatty acid beta-oxidation II (peroxisome) PWY-5136 4.2.1.17
unsaturated, even numbered fatty acid beta-oxidation PWY-5138 4.2.1.17
superpathway of glyoxylate cycle and fatty acid degradation PWY-561 4.2.1.17
superpathway of phenylethylamine degradation PWY-6071 4.2.1.17
4-hydroxybenzoate biosynthesis III (plants) PWY-6435 4.2.1.17
fatty acid beta-oxidation VI (peroxisome) PWY66-391 4.2.1.17
pyruvate fermentation to hexanol (engineered) PWY-6863 4.2.1.17
superpathway of cholesterol degradation I (cholesterol oxidase) PWY-6928 4.2.1.17
superpathway of testosterone and androsterone degradation PWY-6937 4.2.1.17
androstenedione degradation PWY-6944 4.2.1.17
superpathway of cholesterol degradation II (cholesterol dehydrogenase) PWY-6947 4.2.1.17
methyl ketone biosynthesis (engineered) PWY-7007 4.2.1.17
4-coumarate degradation (anaerobic) PWY-7046 4.2.1.17
fatty acid salvage PWY-7094 4.2.1.17
jasmonic acid biosynthesis PWY-735 4.2.1.17
docosahexaenoate biosynthesis III (6-desaturase, mammals) PWY-7606 4.2.1.17
(8E,10E)-dodeca-8,10-dienol biosynthesis PWY-7654 4.2.1.17
Spodoptera littoralis pheromone biosynthesis PWY-7656 4.2.1.17
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase) PWY-7726 4.2.1.17
toluene degradation to benzoyl-CoA (anaerobic) PWY-81 4.2.1.17
L-valine degradation I VALDEG-PWY 4.2.1.17

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MADSLHASGS SVSDSLRASG SSVSDSLHAS GSSADGWKAF TVETTGHIAQ VTLIGPGKGN AMGPDFWREL PLIFTELDAD PEVRAVVLAA AGRHFSYGLD LPAMAGTFMP LMAEKALAKP RTDFLDEIRR LQASVTAVAD CRKPVIAAIQ GWCIGGGVDL IAAADIRYAS SEAKFSVREA KVAIVADIGS LHRLPPIIGD GHLRELAFTG KDIDAARAEK IGLVNDVFDT PEATLAAAHA TAAEIAANPP LVVQGVKDVL GRERENVVAD GLKYVSTWNA AFLPSEDLQE AIGAVFEKRE PDFKGR

NT Sequence
ATGGCTGATT CTCTTCACGC AAGCGGCTCA TCGGTGTCTG ATTCTCTTCG CGCAAGCGGC TCATCGGTGT CTGATTCTCT TCACGCAAGC GGCTCATCGG CCGACGGCTG GAAAGCCTTC ACCGTCGAGA CCACCGGGCA TATCGCACAG GTCACCCTCA TCGGCCCCGG CAAGGGCAAT GCGATGGGCC CCGACTTTTG GCGAGAGCTA CCGCTGATCT TCACCGAGCT CGACGCCGAC CCCGAGGTAC GGGCGGTGGT GCTCGCGGCC GCCGGTCGGC ACTTCAGCTA CGGATTGGAC CTGCCGGCGA TGGCGGGCAC CTTCATGCCG CTTATGGCCG AGAAGGCACT GGCCAAACCG CGCACAGACT TCCTCGACGA GATCCGCCGG CTACAAGCCT CAGTGACAGC CGTCGCCGAC TGCCGCAAGC CGGTGATCGC GGCAATTCAA GGCTGGTGCA TCGGTGGCGG GGTGGATCTC ATCGCCGCCG CCGATATCCG GTACGCCAGC TCCGAGGCAA AGTTCAGCGT GCGCGAGGCC AAGGTGGCGA TTGTGGCCGA TATCGGTTCG CTGCACCGGC TTCCGCCGAT CATCGGTGAC GGCCACCTGC GCGAACTGGC GTTCACCGGC AAGGACATCG ACGCTGCCCG GGCCGAGAAG ATCGGTCTCG TCAACGACGT GTTCGACACC CCCGAAGCGA CGCTGGCCGC CGCGCATGCC ACCGCGGCCG AGATCGCGGC GAATCCCCCG CTGGTGGTGC AGGGCGTCAA GGACGTCCTG GGGCGCGAGC GCGAGAACGT CGTGGCCGAC GGCCTCAAGT ACGTCTCCAC CTGGAATGCC GCGTTCCTGC CGTCGGAGGA TCTACAGGAG GCCATCGGCG CGGTCTTCGA GAAGCGGGAA CCCGACTTCA AGGGGCGC

© 2022 Seattle Children's Research Institute. All rights reserved.